News
45m
Best Life on MSNPeople Are Complaining About Ozempic and Wegovy’s “Life-Ruining” Side EffectDoctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...
Hosted on MSN4mon
Why semaglutide may reduce alcohol cravings, heavy drinking - MSNSemaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, February 13). Low-dose semaglutide reduces alcohol consumption and cravings ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of ...
At 9 weeks, semaglutide led to fewer grams of alcohol consumed during a laboratory self-administration task (β= -0.48, 95% CI -0.85 to -0.11, P=0.01) and lower peak breath alcohol concentration ...
Ozempic, Mounjaro may help with alcohol and opioid addiction, study finds : Shots - Health News The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses ...
Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective at helping people lose weight than diet and exercise alone. But some scientists have also ...
8d
Live Science on MSNOzempic-style drugs treat type 1 diabetes, not only type 2, study findsA clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results